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Summary 
Normal  mouse liver  contains  prominent  subsets  of CD4+8 -  and  CD4-8-  T  cell receptor 
(TCK)-c~/3 + cells  with  intermediate  TCR levels.  We show here that  these cells  express the 
natural  killer  (NK)I.1  surface antigen  and have a restricted TCKV3 repertoire that  is highly 
skewed to V37 and V38.  Surprisingly,  both CD4+8 -  and CD4-8-  subsets of NKI.I+TCR - 
or/3 + cells  are absent in  the liver of 32-mieroglobulin  deficient mice,  which do not express 
major histocompatibility complex (MHC) class I or "class I-like" molecules. Analysis of reciprocal 
radiation bone marrow chimeras established with 32-microglobulin deficient and wild-type mice 
demonstrates  that  MHC class I expression on radiosensitive (presumably hematopoietic) cells 
is required for the development of NKI.1 +TCR-ot/3 + cells in the liver.  In the liver of MHC 
class II deficient mice, the CD4 +8-  and CD4-8-  subsets of NKI.1 +  TCR-od3 + cells develop 
normally. Collectively our data suggest that NKI.1 +TCR-ot/3 § cells in liver require interaction 
with a MHC class I-related ligand on hematopoietic cells for their development. This unusual 
property  of liver  T  cells  is  shared  by a  subset of CD4-8-NKI.I+TCR-ot/3 +  thymocytes, 
suggesting a common lineage independent  of the mainstream  of T  cell development. 
The  presence of MHC class I and II molecules on thymic 
epithelial cells is generally considered to be required for the 
development of mature CD8 + and CD4 + T cells expressing 
the TCR-c~/3.  Recently, mice lacking MHC class I or II 
expression have been created by homologous recombination 
techniques  and  it  has  been dearly  demonstrated  that  the 
majority  of CD8 + or CD4 + T  cells are absent  in  MHC 
class  I  or II deficient mice,  respectively (1-6).  However, a 
very minor  population  of CD4 + T  cells  is reported  to be 
detectable in  the  thymus  and  periphery  of MHC class  II 
deficient mice (4-6).  Moreover, a small subset of CD4-8- 
TCR-c~/3 + thymocytes, which express the NKI.1  marker 
(7, 8) and display a highly skewed V3 repertoire (9, 10), appear 
to  require  MHC  class  I  related  molecules  expressed  on 
hematopoietic cells for their development (11). Hence there 
is some precedent for the existence of T cell subsets that do 
not conform to the general rules of MHC-dependent thymic 
selection. 
A  T  cell subset with  unusual  properties  is abundant  in 
the liver of unmanipulated mice (12-14). These cells, which 
are mainly CD4+8 -  CD4-8-,  represent 40-50% ofT cells 
in liver and display intermediate levels of TCR-ot//3, which 
are approximately threefold lower than LN T  cells (12, 13). 
As T  cells with a similar phenotype appear in old athymic 
mice  (14),  liver  is  proposed  to  be  an  extrathymic  T  cell 
differentiation site. In this study, we show that these unusual 
T cells in the liver of mice express the NKI.1 surface marker 
and display a TCR repertoire highly skewed towards V/37 
and VB8.  Since these cells share many characteristics  with 
thymic CD4-8- TCR-ot/3 + ceils, we decided to investigate 
whether  or  not  the  development  of liver  NKI.I+TCR - 
or/3 + cells is MHC dependent.  Our  data show that  both 
CD4+8 -  and  CD4-8-  subsets of liver NKI.1 +  cells  are 
absent in 32-microglobulin (/32m) deficient mice, which lack 
MHC  class  I  and  "class  I-like"  molecules.  A  possible 
relationship  between  liver  NKI.1 +  T  cells  and  NKI.1 § 
thymocytes will be discussed. 
Materials and Methods 
Mice.  C57BL/6 mice were purchased from Harlan Olac LTD 
(Bicester, UK). ~2m deficient (-/-)  mice (1, 2) and wild-type 
(+/-) littermates were bred and maintained in the animal facilities 
of the Swiss Institute for Experimental Cancer Research (Epalinges, 
Switzerland).  In most experiments,  32m  -/-  mice used were 
originally crossed with C57BL/6 mice and the C57BL/6 back- 
ground was confirmed by staining with an anti-NKl.1 mAb. MHC 
class II deficient Ac~  -/-  mice (6) and wild-type (+/-) litter- 
mates on a C57BL/6 background were kindly provided by Dr. H. 
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Cell  Preparation.  Mononuclear cells (MNC)  from  thymus, 
spleen, LN, and bone marrow were obtained by standard methods. 
To obtain liver MNC (15), the liver was pressed through stainless 
steel mesh and suspended in 50 ml of PBS. After being washed 
once with PBS, the cells (including MNC and hepatocytes) were 
fractionated by discontinuous (40 and 80%) Percoll gradient cen- 
trifugation for 10 rain at 900g. The interface  was harvested, washed 
with  5%  FCS  PBS  and  used for  experiments. To  obtain in- 
traepithelial lymphocytes (IEL), small intestine dissected free of 
Peyer's patches was opened longitudinally, washed with PBS, and 
cut into 5-mm pieces (16). Subsequently,  these pieces were incubated 
in  PBS  supplemented with  2  mM  dithiothreitol  and  4  mM 
NaHCO3,  with stirring for 20 min at 37~  The supernatant, 
containing IEL and epithelial cells, was washed with 5% FCS PBS, 
and fractionated by discontinuous (40 and 80%) Percoll gradient 
centrifugation for 10 rain at 900 g. The interface was harvested 
and washed with 5% FCS PBS. 
Thymocytes expressing  low levels of heat stable antigen (HSA), 
which were used as a source of NKI.1 + thymocytes for the on- 
togeny study, were obtained by treatment of whole thymocytes 
with IgM mAb B2A2 (anti-HSA) in the presence of rabbit com- 
plement (17). Recovered cells (2-3%)  were purified by Ficoll- 
Isopaque gradient centrifugation. 
Radiation Bone Marrow Chimeras.  To make reciprocal chimeras 
between Bzm deficient  and wild-type mice, redpients were lethally 
irradiated (950 rad, 117 rad/min, t37Cs source) and reconstituted 
1 d later with 15-20  x  106 T cell-depleted bone marrow cells. 
For the following 8 wk, teramycin (1.5 g/liter) was added to the 
drinking water. Chimeras were killed 10 wk after reconstitution 
and chimerism was monitored by flow microfluorometry analysis 
using B8-24-3 (anti-K  b) mAb. 
Antibodies and Flow Cytometric Analysis.  The following mAb 
conjugates  were used in this study: H57-597-PE (anti-TC1LS;  Caltag 
Laboratories, San Francisco, CA); PK136-biotin (anti-NKl.1; Phar- 
mingen, San Diego, CA); GK1.5-PE and GK1.5-FITC (anti-CD4; 
Becton Dickinson & Co., Mountain View, CA); 53-6.7-FITC (anti- 
CD8).  Unconjugated rat, mouse, or hamster mAbs against the 
following TCR V/~ domains were prepared in our laboratory: 
B20.6.5 (anti-V~2); KJ25 (anti-V~3); KT4-10 (anti-VB4); MR9-4 
(anti-V/~5); 44-22.1 (anti-V~6); TR310  (anti-VB7); F23.1 (anti- 
V~8.1,8.2,8.3); F23.2 (anti-V~8.2); MR10-2 (anti-Vj~9); B21.5 (anti- 
VB10); and RR3-15 (anti-V/~11). FITC-conjugated goat anti-rat 
Ig  (Caltag  Laboratories) or  goat  anti-mouse  IgG1 or  IgG2a 
(Southern Biotechnology Associates, Inc., Birmingham, AL) were 
used with unconjugated mAbs. Rat or mouse Ig was used to block 
free Ig sites  before addition of  anti-CD4-PE and anti-NKl.l-biotin. 
All samples were further stained with streptavidin Tri-color and 
analyzed  by FACScan  |  and the Lysis  II program (Becton  Dickinson 
& Co.). 
Results 
Liar  Is  a  Major  Source of  NKLI +TCR-~/~ §  Cells. 
40-50% of total MNC in the liver of 8-10-wk-old C57BL/6 
mice are TCR-o~/B + (12-14).  As shown in Fig.  1,  about 
half  of  these  cells  express  NKI.1.  The  NKI.1 +- 
TCIL-c~/B +  subset  in  liver  had  approximately  threefold 
lower  surface  TCR-B  intensity than  NKI.I-TCR-oJB + 
cells in liver, LN, and spleen (Fig. 1). This phenotype clearly 
corresponds to the so-called  "intermediate" T  cells in liver 
which  express  TCR-B  and  CD3  at  levels  higher  than 
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Figure 1.  Tissue  distribution  of NKI.1  +  TCR-c~/~  + cells.  Total  MNC 
separated from  indicated  organs of 8-wk-old C57BL/6 mice  were stained 
with H57-597-PE (anti-TCRB,  vertical  axis) and PK136-Biotin  (anti-NKl.1, 
horizontal axis) plus streptavidin  Tri-color. One representative  experiment 
is shown. The numbers correspond to the proportion of NKI.1- or 
NKI.I+TCR-c~/B  + cells among MNC in each organ. 
CD4 +  8 + thymocytes but lower than mature T cells (12-14). 
Since the total number of MNC recovered per liver was 5.0 +_ 
1.2  x  106, the absolute number of NKI.I+TCR-c~/3 + cells 
was 106. NKI.1 +TCR-oJ3 § cells were rather rare in other 
organs, i.e., 0.5% in thymus, LN, and bone marrow, 1.5% 
in spleen,  and 0.3%  in IEL (Fig.  1).  Thus, NKI.I+TCR  - 
ot/~ + cells  were most  frequently seen in liver.  However, 
15-20% of HSN  ~  thymocytes in adult C57BL/6 mice were 
NKI.1 +  TCR-cffB + (data not shown) as reported elsewhere 
(18, 19). NKI.I+TCR-c~/B + cells or "intermediate" TCR 
cells in thymus and liver appear  shortly after birth and in- 
crease with age (14, 18, 20).  As shown in Fig.  2,  neonatal 
liver contains 10-fold more NKI.I*TCR-c~/B + cells than 
thymus;  however  the  absolute  number  of NKI.I+TCR  - 
ol//~ + cells in these organs is approximately equal in the 
adult. 
We further analyzed the CD4/CD8  phenotype of liver 
NKI.I+TCR-ol/~ + cells. As shown in Table 1,  they were 
comprised mainly of CD4+8 -  cells  (65%)  and CD4-8- 
cells  (30%).  A  small  subset  of CD4-8 +  NKI.I+TCR  - 
o~/B + cells was also detectable (5%). 
TCR-V~ Usage of NK1.1 +  TCR-cr/fl + Cells in Liver.  A 
previous study (13) has shown that V~8 is overrepresented 
among TCR intermediate cells in liver. TCR-V~ expression 
on the surface of NKI.I+TCR-c~/B + liver cells and control 
700  MHC Class I-dependent Development of NKI.I+TCR-c~/fl  + Liver  T Cells Figure  2.  Ontogeny  of NKI.I+TCR.-ol/~ +  cells  in  the  liver  and 
thymus  of C57BL/6  mice.  At indicated  time points,  liver MNC and 
HSA  l~  thymocytes (prepared as described in Materials and Methods) were 
stained with H57-597-PE  and  PK136-biotin  plus  streptavidin  Tri-color. 
The absolute  number of NKI.I+TCR-oe/fl  + cells per organ is shown. 
Figure  3.  TCR-V~ repertoire  of CD4 + LN cells, CD4 +  NKI.1 § and 
CD4-8-NKI.1 +  liver  T  cells. Cells  were  pooled  from  three  to  five 
C57BL/6 mice aged 8 to 10 wk and stained with a panel ofanti-VB mAbs. 
Each bar represents  the average of two to three experiments. 
LN cells was therefore investigated using a panel of mAbs 
(Fig.  3).  CD4+NKI.1 +  T  cells  in liver use VB8 (69.8  + 
0.9%), vB7 (16.0 •  1.3%), and V~2 (8.2 •  0.3%) at much 
higher  frequency when  compared with  CD4 + LN T  cells 
(21.4  •  1.5, 1.4 +  0.2, and 6.1  •  0.3%, respectively). Among 
the V/38 family, VflS.2 (55.0  •  1.4%) is dominant.  Other 
V~8 such as V~4, VB6, VB10, and Vflll were virtually ab- 
sent in CD4+NKI.1 + T  cells.  The V~/usage of CD4-8- 
NKI.1 +  T  cells  was similar  to CD4+NKI.I+T  cells,  i.e., 
67.5  •  8.5% VB8 and 22.0  •  4.1% V~7. It is noteworthy 
that  the  intensities  of V~88,  7,  and  2  staining  of CD4 + 
NKI.1 § T cells were somewhat lower than those of CD4 + 
LN T  cells  (data not shown).  It is interesting  to note that 
both CD4- 8-  and CD4 +  8-  subsets of NKI.1 +  TCR-ol/~ + 
cells in thymus also overexpress V~8, mainly VB8.2 (9-11, 
18, 21).  The similarity of phenotype and Vfl usage suggest 
that  CD4+NKI.1 +  T  cells in  liver  and  thymus  are more 
Table  1.  CD4/CD8  PhenotyFe  of NKI.I +  TCR-cr/fl + Cells 
in  the Liver 
Percent  positive among 
NKI.I+TCR-~/fl +  NKI.I-TCR-c~/fl  + 
Subset  cells  cells 
% 
CD4+8 -  65.0,  68.3  65.0,  59.6 
CD4-8 +  6.5,  4.9  34.0,  34.5 
CD4-8-  30.1,  29.5  2.0,  2,6 
The numbers  indicate  results  from separate experiments.  Pools of two 
to four C57BL/6 mice were used  in each  experiment, and liver cells 
were stained  with  CD4-FITC and/or  CDS-FITC,  H57-597-PE,  and 
NK1.1-biotin plus  avidin Tri-color. 
closdy related to CD4-8-NKI.1 + T  cells  than  to conven- 
tional  CD4+NKI.1 -  T  cells  (18,  21). 
Impaired Development  of NKI.1 +  TCR-cr/fl + Ceils in  the 
Liver of~2m Deficient Mice.  To investigate the possible role 
of MHC or MHC-related molecules in the development of 
NKI.I+TCR-oJB §  cells  in  liver,  we  compared  the  fre- 
quency of these cells  in  fl2m  and  Ac~ deficient  mice on  a 
C57BL/6  (NKI.1 +)  background.  The  former  mice  (1,  2) 
failed  to express conventional MHC dass  I  molecules (H- 
2K, H-2D, and H-2L) as well as other fl2m-associated pro- 
teins  such as Qa,  Tla,  Hint,  and  CD1,  whereas  the latter 
(6) lacked conventional MHC class II molecules.  Surprisingly, 
NKI.I+TCR-c~/B + cells  were decreased by >90%  in  the 
liver of ~2m  -/-  mice as compared with  their littermate 
32m  +/-  controls  (Fig.  4  and  Table  2).  This  dramatic 
reduction  was  apparent  in  both  CD4+8 -  and  CD4-8- 
subsets of NKI.I+TCR-oJB + cells.  In  the liver of MHC 
class  II  deficient  (Aoe  -/-)  mice,  the  development  of 
NKI.I+TCR-c~/3 +  cells  was  essentially  normal  for both 
CD4 +8-  and CD4-8-  subsets (Fig.  4 and Table 2),  Thus, 
the  behavior  of NKI.I+TCR-c~/3 +  cells  in  the  liver  of 
MHC deficient mice is strikingly similar to that reported re- 
cently for CD4-8-NKl.l+thymocytes,  which  also appear 
to require MHC class I-related molecules for their develop- 
ment  (11). 
MHC Class 1-related Molecules on Hematopoietic Cells Control 
the Development of NKl.1 +  TCR-cr/fl + Cells in Liver.  The 
mechanism  underlying  the  failure  of NKI.I+TCR-od~8 + 
cells  to develop in the liver of B2m deficient mice was fur- 
ther investigated in radiation bone marrow chimeras.  Con- 
ventional thymus-derived CD4 + or CD8 + T  cells primarily 
dependent upon interactions with MHC molecules on radi- 
oresistant (presumably epithelial) cells in the thymus of such 
chimeras  in order to be positively selected during develop- 
ment  (22).  In  contrast,  the  development  of the  CD4+8 - 
NKI.1 +TCR-c~/B + subset in the liver of reciprocal radia- 
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Figure  4.  Analysis  of NKI.1 + 
TCR.-c~/~+  cells  in  the  liver  of 
MHC deficient mice. For the detec- 
tion of NKI.1 +  TCR.-od~ + cells or 
CD4+NKI.1 +  calls, liver  MNC 
were stained with H57-597+PE or 
CD4-PE  and  PK136-biotin  plus 
streptavidin  Tri-color. For the de- 
tection  of  CD4-8-TC1L-c~/13 + 
cells, liver MNC were stained with 
CD4-FITC, CD8-FITC, and H57- 
597-PE. 
tion  bone  marrow  chimeras  established  between  /32m 
deficient and wild-type mice correlated strictly with the pres- 
ence of ~2m + cells of donor (but not host) origin (Table 3). 
These CD4+8-NKI.1 §  cells  had  a TCR  repertoire  that 
was highly skewed towards VB8 (Table 3), confirming the 
phenotype observed for this subset in normal mice (Fig. 3). 
Collectively, our data indicate that the expression of MHC 
class I-related molecules on radiosensitive (presumably he- 
matopoietic)  cells  is  required  for  the  development  of 
NKI.I+TCR-odB + cells in liver.  It is interesting to note 
that  a  similar  conclusion  has  recently  been  reached  for 
CD4-8-NKI.1 + cells in thymus (11),  suggesting that the 
development of NKI.I+TCR-odB +  cells  in both  organs 
does not follow the conventional rules of MHC-dependent 
selection on thymic epithelial cells. 
Discussion 
Our data indicate that a ligand expressed on hematopoi- 
etic  cells  and  necessary for  the  development of NKI.I+- 
TCR-odB + cells in liver is lacking in B2m deficient mice. 
As discussed earlier,  this putative selecting ligand could be 
Table  2.  Analysis  of NK1.1 +  TCR-cr/fl + Cells in  the  Liver of ~2m  or Aot  Deficient Mice 
Liver 
(Percent  NKI.I+TCR-c~/~ +) 
LN 
(Percent  NKI.I-TCR-a/fl  § 
Mice  Total  CD4 +8-  CD4-8-  CD4- 8 +  CD4 +  8-  CD4- 8 + 
%  % 
/~2m+/-  26.8  _+  4.3  17.2  __  2.9  7.3  __  0.7  1.0  +_  0.3  37.3  _+  4.4  28.5  +_  2.5 
~2m-/-  1.6  _+  0.5  0.9  _+  0.3  1.2  _  0.2  0.4  +_  0.2  45.7,  51.3  0.4  _+  0.2 
Au+/-  29.5,  34.2  19.8,  23.4  8.8,  12.3  0.7,  ND  39.4,  28.2  33.1,  25.6 
Aol-/-  35.2,  32.7  23.5,  22.1  13.2,  11.3  ND  1.6,  0.9  72.2,  76.8 
Liver MNC from control or mutant mice were analyzed for NKI.1 +TCR-t~//3+ cells as in Fig. 4. Data are mean  +_  SD of three to five mice un- 
less otherwise indicated  (values for individual  mice).  LN cells are included  for comparison. 
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Radiation Bone Marrow Chimeras Established between B2m 
Deficient (-) and Wild-type (+) Mice 
Donor  Host 
Percent  Percent  V/~8  + in 
NKI.1 § 
in CD4 +  NKI.I+CD4 +,  NKI.I-CD4 § 
%  % 
+  +  7.4,  8.9  61.2,  63.6  27.7,  29.8 
+  -  7.6,  4.4  53.8,  53.4  27.9,  22.1 
-  +  1.3,  1.0  ND  22.9,  24.1 
-  -  1.1, 0.9  ND  25.1,  27.6 
Liver MNC from two individual mice were analyzed in each group. 
Chimerism was checked by staining with B8-24-3 (anti-K  b) mAb and 
cells were analyzed after excluding host-derived cells in (+  to  -) and 
( -  to + ) cases. The proportions of donor-derived  cells were 92%, 73% 
in (+  to  -) chimeras and 74%, 76% in (-  to  +) chimeras. 
ND, not detectable because of the small percentage of NKI.1 +CD4+ 
cells. 
either a classical MHC class I molecule or some other ~2m- 
associated  protein such as the product of the Qa, Tla, Hmt, 
or CD1  locus.  Since NKI.I+TCR-oJ/~ + cells in liver are 
primarily of the CD4 +  8-  or CD4- 8-  (but not CD4- 8 +) 
phenotype, selection by a classical MHC class I molecule seems 
rather unlikely. Rather, we would propose that the develop- 
ment of NKI.1 +TCR-ce/B + cells in liver depends upon in- 
teraction of the TCR with a nonclassical class  I molecule. 
Since the latter class of molecules is relatively nonpolymorphic 
(23) and (at lease in some cases) appears to present a limited 
number of peptides (24,  25),  such an interaction could ac- 
count for the highly restricted TCR V~ usage of NKI.1 + 
TCR-ol/~ + cells. In the context of this model, the fact that 
several antigens of microbial origin can be presented by non- 
classical  class I molecules (26,  27)  is of particular interest, 
since "TCR-cz//3 intermediate" (presumably NKI.1 +) cells 
in liver have been shown to expand dramatically during bac- 
terial infections (12). 
The origin of NKI.I+TCR-ce/B +  cells in liver is con- 
troversial (28). In this respect, the striking similarities in TCR 
VB phenotype and MHC class  I  dependence observed for 
NKI.1 +TCR-cff/~ + cells in thymus and liver raise obvious 
questions concerning a possible common lineage indepen- 
dent of the mainstream of T cell development. Indeed, it has 
been  shown  that  some  NKI.I+TCR-c~/B +  cells  in  the 
spleen of young athymic mice can originate from a grafted 
neonatal  thymus  (8).  On  the  other  hand  NKI.I+TCR - 
cr/~ + cells  (or cells  with a similar phenotype) clearly de- 
velop to some extent in several organs (including spleen and 
liver) of aged nude mice (14, 20, 29), arguing against an oblig- 
atory thymic origin of these cells. Given the apparent require- 
ment for hematopoietic (rather than epithelial) cells for their 
generation,  it  remains  possible  that  NKI.I+TCR-cz/B + 
cells develop independently at multiple sites of hematopoiesis. 
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